Higher circulating free IGF-1 in obese patients (Yakar et al., 2001; Frystyk et al., 1995)Altered plasma levels of IGF-BPs and free IGF-1 in T2DM patients (Clemmons, 2018). This evidence concerns the gene IGF1 and type 2 diabetes mellitus.